PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples

Purpose The discovery of new diagnostic tools for the diagnosis of prostate cancer (PCa) has become an important field of research. In this study, we analyzed the diagnostic value of the expression of the pepsinogen C (PGC) and prostate-specific membrane antigen (PSMA) genes in tissue samples obtained from prostate biopsies. Materials and Methods This study was comprised of 51 consecutive patients who underwent transrectal ultrasound (TRUS)-guided prostate biopsies between January 2010 and March 2010. The biopsies were performed with 12 cores, and an additional core was randomly retrieved from the peripheral zone from each patient for study purposes. The expression of the PGC and PSMA genes was analyzed from the cDNA from the samples via the qRT-PCR technology. The expression patterns of patients with PCa were compared with those of patients without a PCa diagnosis. Results PSMA was overexpressed in only 43.4% of PCa cases, and PGC was overexpressed in 72.7% of cases. The median expression of PSMA was 1.5 times (0.1 to 43.9) and the median PGC expression was 8.7 times (0.1 to 50.0) the expression observed in prostatic tissue from TRUS-guided biopsies of normal patients. Analysis of patients with high-risk PCa indicated that PGC was overexpressed in 71.4% of cases (with a median expression of 10.6 times), and PSMA was overexpressed in only 35.7% of cases (with a median expression of 4.5 times). Among patients with low-risk PCa, PGC was also overexpressed in 71.4% of cases (with a median expression of 5.9 times), and PSMA was overexpressed in only 42.8% of cases (with a median expression of 2.5 times). Conclusions PGC gene expression is significantly higher in prostatic tissue in men affected by PCa when compared to normal prostates. Further analyses are necessary to confirm our results.

Saved in:
Bibliographic Details
Main Authors: Antunes,Alberto A., Reis,Sabrina T., Leite,Katia R., Real,Danilo M., Sousa-Canavez,Juliana M., Camara-Lopes,Luiz H., Dall'oglio,Marcos F., Srougi,Miguel
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000500649
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382013000500649
record_format ojs
spelling oai:scielo:S1677-553820130005006492013-11-29PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samplesAntunes,Alberto A.Reis,Sabrina T.Leite,Katia R.Real,Danilo M.Sousa-Canavez,Juliana M.Camara-Lopes,Luiz H.Dall'oglio,Marcos F.Srougi,Miguel Prostate Prostatic Neoplasms Biopsy Diagnosis Gene Expression PSMA ADC [Supplementary Concept] Purpose The discovery of new diagnostic tools for the diagnosis of prostate cancer (PCa) has become an important field of research. In this study, we analyzed the diagnostic value of the expression of the pepsinogen C (PGC) and prostate-specific membrane antigen (PSMA) genes in tissue samples obtained from prostate biopsies. Materials and Methods This study was comprised of 51 consecutive patients who underwent transrectal ultrasound (TRUS)-guided prostate biopsies between January 2010 and March 2010. The biopsies were performed with 12 cores, and an additional core was randomly retrieved from the peripheral zone from each patient for study purposes. The expression of the PGC and PSMA genes was analyzed from the cDNA from the samples via the qRT-PCR technology. The expression patterns of patients with PCa were compared with those of patients without a PCa diagnosis. Results PSMA was overexpressed in only 43.4% of PCa cases, and PGC was overexpressed in 72.7% of cases. The median expression of PSMA was 1.5 times (0.1 to 43.9) and the median PGC expression was 8.7 times (0.1 to 50.0) the expression observed in prostatic tissue from TRUS-guided biopsies of normal patients. Analysis of patients with high-risk PCa indicated that PGC was overexpressed in 71.4% of cases (with a median expression of 10.6 times), and PSMA was overexpressed in only 35.7% of cases (with a median expression of 4.5 times). Among patients with low-risk PCa, PGC was also overexpressed in 71.4% of cases (with a median expression of 5.9 times), and PSMA was overexpressed in only 42.8% of cases (with a median expression of 2.5 times). Conclusions PGC gene expression is significantly higher in prostatic tissue in men affected by PCa when compared to normal prostates. Further analyses are necessary to confirm our results. info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.39 n.5 20132013-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000500649en10.1590/S1677-5538.IBJU.2013.05.06
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Antunes,Alberto A.
Reis,Sabrina T.
Leite,Katia R.
Real,Danilo M.
Sousa-Canavez,Juliana M.
Camara-Lopes,Luiz H.
Dall'oglio,Marcos F.
Srougi,Miguel
spellingShingle Antunes,Alberto A.
Reis,Sabrina T.
Leite,Katia R.
Real,Danilo M.
Sousa-Canavez,Juliana M.
Camara-Lopes,Luiz H.
Dall'oglio,Marcos F.
Srougi,Miguel
PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
author_facet Antunes,Alberto A.
Reis,Sabrina T.
Leite,Katia R.
Real,Danilo M.
Sousa-Canavez,Juliana M.
Camara-Lopes,Luiz H.
Dall'oglio,Marcos F.
Srougi,Miguel
author_sort Antunes,Alberto A.
title PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
title_short PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
title_full PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
title_fullStr PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
title_full_unstemmed PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
title_sort pgc and psma in prostate cancer diagnosis: tissue analysis from biopsy samples
description Purpose The discovery of new diagnostic tools for the diagnosis of prostate cancer (PCa) has become an important field of research. In this study, we analyzed the diagnostic value of the expression of the pepsinogen C (PGC) and prostate-specific membrane antigen (PSMA) genes in tissue samples obtained from prostate biopsies. Materials and Methods This study was comprised of 51 consecutive patients who underwent transrectal ultrasound (TRUS)-guided prostate biopsies between January 2010 and March 2010. The biopsies were performed with 12 cores, and an additional core was randomly retrieved from the peripheral zone from each patient for study purposes. The expression of the PGC and PSMA genes was analyzed from the cDNA from the samples via the qRT-PCR technology. The expression patterns of patients with PCa were compared with those of patients without a PCa diagnosis. Results PSMA was overexpressed in only 43.4% of PCa cases, and PGC was overexpressed in 72.7% of cases. The median expression of PSMA was 1.5 times (0.1 to 43.9) and the median PGC expression was 8.7 times (0.1 to 50.0) the expression observed in prostatic tissue from TRUS-guided biopsies of normal patients. Analysis of patients with high-risk PCa indicated that PGC was overexpressed in 71.4% of cases (with a median expression of 10.6 times), and PSMA was overexpressed in only 35.7% of cases (with a median expression of 4.5 times). Among patients with low-risk PCa, PGC was also overexpressed in 71.4% of cases (with a median expression of 5.9 times), and PSMA was overexpressed in only 42.8% of cases (with a median expression of 2.5 times). Conclusions PGC gene expression is significantly higher in prostatic tissue in men affected by PCa when compared to normal prostates. Further analyses are necessary to confirm our results.
publisher Sociedade Brasileira de Urologia
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000500649
work_keys_str_mv AT antunesalbertoa pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT reissabrinat pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT leitekatiar pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT realdanilom pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT sousacanavezjulianam pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT camaralopesluizh pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT dallogliomarcosf pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
AT srougimiguel pgcandpsmainprostatecancerdiagnosistissueanalysisfrombiopsysamples
_version_ 1756428140216844288